Dynex Capital Investing Cash Flow decreased by 202.9% to -$7.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 691.4%, from -$908.36M to -$7.19B. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 144.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$323.76M | -$294.67M | -$335.28M | $25.16M | $491.19M | -$787.82M | -$332.26M | -$1.24B | -$834.34M | -$555.97M | $232.60M | -$335.29M | -$955.25M | $0.00 | -$908.36M | -$1.51B | -$3.29B | -$2.37B | -$7.19B |
| QoQ Change | — | +9.0% | -13.8% | +107.5% | >999% | -260.4% | +57.8% | -272.4% | +32.6% | +33.4% | +141.8% | -244.1% | -184.9% | +100.0% | — | -65.7% | -118.4% | +27.8% | -202.9% |
| YoY Change | — | — | — | — | +251.7% | -167.4% | <-999% | -351.9% | -5.9% | — | +170.0% | +72.9% | -14.5% | +100.0% | -490.5% | -348.9% | -244.2% | — | -691.4% |